CADL (Candel Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Candel Therapeutics, Inc. Common Stock (CADL) is a publicly traded Healthcare sector company. As of May 21, 2026, CADL trades at $7.63 with a market cap of $578.83M and a P/E ratio of -10.76. CADL moved +0.78% today. Year to date, CADL is +45.47%; over the trailing twelve months it is +30.46%. Its 52-week range spans $3.79 to $14.60. Analyst consensus is strong buy with an average price target of $21.17. Rallies surfaces CADL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CADL stock inside the company?

Recent CADL insider activity includes Manning Paul B bought 550.46K, Nichols William Garrett sold 937, Nichols William Garrett sold 781, Tak Paul Peter sold 400, and Nichols William Garrett sold 45.32K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CADL Key Metrics

Key financial metrics for CADL
MetricValue
Price$7.63
Market Cap$578.83M
P/E Ratio-10.76
EPS$-0.72
Dividend Yield0.00%
52-Week High$14.60
52-Week Low$3.79
Volume1.31K
Avg Volume0
Revenue (TTM)$0
Net Income$-38.18M
Gross Margin0.00%

Recent CADL Insider Trades

  • Manning Paul B bought 550.46K (~$3.00M) on Feb 23, 2026.
  • Nichols William Garrett sold 937 (~$6.54K) on Jul 28, 2025.
  • Nichols William Garrett sold 781 (~$3.94K) on Jun 30, 2025.
  • Tak Paul Peter sold 400 (~$3.60K) on Mar 19, 2025.
  • Nichols William Garrett sold 45.32K (~$397.00K) on Mar 18, 2025.

Latest CADL News

CADL Analyst Consensus

6 analysts cover CADL: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.17.

Common questions about CADL

Who is trading CADL stock inside the company?
Recent CADL insider activity includes Manning Paul B bought 550.46K, Nichols William Garrett sold 937, Nichols William Garrett sold 781, Tak Paul Peter sold 400, and Nichols William Garrett sold 45.32K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CADL?
Yes. Rallies tracks CADL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CADL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CADL. It does not provide personalized investment advice.
CADL

CADL